ABSTRACT
INTRODUCTION
Fish oil (FO), enriched in n-3 polyunsaturated fatty acids (PUFAs), is increasingly hypothesized to have beneficial health effects for treating symptoms for a wide range of diseases associated with chronic inflammation (1) (2) (3) . However, several hurdles have prevented the therapeutic use of FO in the clinic including a limited understanding of the molecular targets and mechanisms of n-3 PUFAs. The proposed mechanisms by which n-3 PUFAs of FO, eicosapentaenoic acid (EPA) and docosahexaenoic (DHA) acid, exert immunosuppressive effects are pleiotropic (4) . These include incorporating into membrane phospholipids and modifying plasma membrane microdomain organization, serving as precursors for bioactive lipid molecules, disrupting intracellular signaling and regulating gene expression (4) . Recently, manipulation of lipid raft microdomains with n-3 PUFAs has gained attention since this mode of action is central to many of the downstream effects of n-3 PUFAs (5).
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(OVA 323-339 ) presented by H-2 IAb molecules. For in vitro studies, mouse EL4 lymphomas were treated with 25 µM EPA or DHA complexed to BSA for 15.5 hours as previously described (18). BSA without complexed fatty acid served as the control (18).
Isolation of detergent resistant membranes and analysis. 30x10 6 B cells or 20x10 6 EL4 cells were prepared for detergent extraction and layered on a sucrose gradient as previously described (18). Sucrose gradients were centrifuged at 40,000 rpm for 20 h at 4°C in a swinging bucket SW41Ti rotor (Beckman). Twelve 1 mL fractions were collected. Fractions 3-6 representing detergent resistant membranes (DRMs), or 9-12
representing detergent soluble membranes (DSMs), were combined based on their cholesterol content, measured with an Amplex Red cholesterol assay kit (Invitrogen) relative to protein levels. Lipids were extracted as described previously (18). Samples were dissolved in chloroform and select phospholipids were separated with a Shimadzu
Prominence HPLC using a 150 x 4.6 mm Luna 5 µm NH 2 column (Phenomenex) with a mobile phase gradient of H 2 O (increasing from 5% to 50%) and acetonitrile (decreasing from 95% to 50%) at 30°C. Phosphatidylethanolamine (PE), phosphatidylcholine (PC), and sphingomyelin (SM) fractions were collected by UV detection at 202 nm and the acyl chain composition of each fraction was further analyzed by GC as previously shown (18). The rationale for selecting these phospholipids was to address the most abundant lipids of the outer (PC, SM) and inner (PE) leaflets and to allow direct comparison with other studies (19).
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2 H NMR spectroscopy. Sample preparation, NMR spectroscopy, and analysis were as previously described (7). The PC phospholipid (1- Lipid raft cross-linking and TIRF imaging. Cells were fluorescently stained for lipid rafts by cross-linking cholera toxin subunit B-FITC (CTxB) (Invitrogen) and then imaged using total internal reflection fluorescence (TIRF) microscopy. For select experiments, GM1 levels were measured by staining with anti-CTxB with no secondary antibody for cross-linking. TIRF was performed on an Olympus IX-71 microscope with excitation at 488 nm by a 20 mW Sapphire laser and a 60x 1.45NA oil-immersion TIRF objective.
Fluorescence emission was filtered through a LF-488/561-A-OMF filter cube (Semrock) and detected by a Hamamatsu ORCA-R2 progressive scan interline CCD camera. For all imaging experiments, 9-10 cells per diet were analyzed per experiment and image analysis was performed as previously described (18). from animals since prior to experimentation we predicted an increase in n-3 PUFA levels (19). In vitro studies relied on one-way ANOVAs followed by a Dunnett's post hoc t test (16) . P values less than 0.05 were considered significant. The NMR data were not analyzed for statistical significance since they were obtained on model membranes of well-defined and controlled composition for which a reproducibility of ±1% applies to multiple acquisitions. This approach is standard for model membrane studies using NMR spectroscopy (7, 8).

RESULTS
Body weights, food intake, and cellularity. The FO diet, relative to CON, had no effect on the rate of body weight gain (Suppl. Fig. 1A ) or food intake per day (Suppl . Fig.   1B ). Spleen weight (Suppl. Fig. 1C ) was significantly elevated for mice on the FO diet but did not impact the steady state number of B cells (data not shown). Given that we recently reported n-3 PUFAs at high doses lower energy expenditure (24), we verified the FO diet had no impact on whole body energy expenditure using metabolic cages (data not shown).
FO promoted uptake of EPA/DHA into DSMs and DHA into PC of DRMs. The first objective was to biochemically determine if the physiologically relevant dose of FO manipulated the molecular composition of B cell "raft"-like DRMs. We used detergent extraction, followed by HPLC-GC to determine the acyl chain composition of PE, PC and SM ex vivo (Fig. 1) . The relative proportion of PC, PE, and SM in DRM and DSM fractions was not changed by FO (Fig. 1A) . Relative PC and SM levels were generally higher in DRMs than DSMs. SM was the smallest fraction of PE/PC/SM, consistent with studies in other cell types (25).
In PE, EPA (20:5) and DHA (22:6) did not incorporate into DRMs but were significantly increased in DSMs (Fig. 1B) . FO also increased 22:5 and lowered arachidonic acid (20:4) in PE DSMs (Fig. 1B) . In PC, 20:5 was lowered and 22:6 increased with FO in DRMs (p=0.06) (Fig. 1C) . In DSMs of PC, 20:5 and 22:6 did not significantly increase (Fig. 1C) . In SM, 20:5 and 22:6 did not change in DRMs (Fig. 1D ).
In DSMs of SM, FO significantly decreased palmitic acid (16:0), increased stearic acid Cholesterol levels in DRM and DSM fractions were not changed with FO (Suppl. Table 2 ). We also analyzed the ratio of DRM to DSM cholesterol based on a very recent study that reported DHA treatment in vitro increased cholesterol into DSMs when analyzed as a ratio (9). FO had no effect on the ratio (Suppl Table 2 ).
Overall, the data were highly consistent with predictions from detergent-free model membrane studies in which PCs containing DHA were found to have higher solubility for cholesterol, and by implication more favorable interactions with rafts, than Table 2 ). The increase in order due to cholesterol (reflecting proximity), measured for the PC containing DHA was more than twice that for the PE-containing DHA (Table 2 ). This observation was consistent with the ex vivo biochemical data to suggest DHA infiltrated into PCs of DRMs and PEs of DSMs.
FO increased B cell lipid raft size induced by cross-linking GM1. The next objective
was to measure changes in raft organization with the FO diet relative to CON diet using microscopy. This was essential since biochemical approaches are a useful predictive tool but also have limitations due to the use of detergent (28, 29). TIRF imaging of B cells from FO and CON fed mice showed a significant difference in the spatial distribution of GM1 molecules cross-linked with CTxB ( Fig. 2A) . TIRF image analysis, confirmed with confocal image analysis (data not shown), revealed the Feret's diameter was increased by 79% with FO relative to CON (Fig. 2B ). The binding of CTxB to GM1
in the presence of cross-linking, measured in terms of fluorescence intensity, showed on average a 36% increase with FO, but this failed to reach statistical significance with TIRF analysis (Fig. 2C ). To determine if the propensity for an increase in CTxB intensity was due to increased surface levels of GM1, the binding of CTxB in the absence of cross-linking was measured, which revealed a 49% increase in intensity with FO ( Fig.   2D ). To ensure the observed effects were FO specific, we also measured raft size and binding of CTxB with a safflower oil-enriched diet and found no evidence of raft disruption with this diet (Suppl. Fig. 2 ). We also ensured the effects were specific for rafts. Changes in non-raft organization were measured in terms of uptake of the non-raft probe DiIC 18 (21). Live cell imaging revealed DiIC 18 uptake was identical between cells isolated from CON and FO fed mice (Suppl. Fig. 3 ). The imaging results provided the first evidence that a physiologically relevant dose of FO disrupted raft, but not non-raft, organization.
FO increased membrane order upon cross-linking rafts relative to the absence of cross-linking. We subsequently determined if the aforementioned changes with FO on raft organization impacted membrane molecular order. This directly addressed two opposing models in which n-3 PUFAs in response to stimulation increase membrane order ex vivo versus a decrease in membrane order in vitro (6, 25) . To measure molecular order, we used di-4-ANEPPDHQ, an environmental sensing fluorescent dye that can shift its emission spectra 30 nm depending on the degree of packing in the surrounding lipid chains (Fig. 3A ) (30) . As an initial control, B cells were treated with 10 µM mβCD to remove cholesterol from the membrane. GP significantly decreased upon cholesterol depletion (data not shown). In the absence of cross-linking, FO, compared to CON, significantly decreased the average GP by 25% (Fig. 3B ). This decrease was consistent with data that n-3 PUFAs exert a disordering effect on membrane microviscosity in the absence of inducing raft formation (31) . Although there was no difference in GP values between CON and FO diets upon cross-linking ( Fig. 3C) , GP values for FO were elevated to a greater extent than CON relative to no cross-linking ( Fig. 3D) . Analysis of the differences in GP values between cross-linking and no crosslinking showed FO had a greater ordering effect by 65% compared to CON (Fig. 3D ).
These results supported the ex vivo model that FO is capable of exerting an ordering effect on the membrane upon stimulation (6).
EPA and DHA incorporated into DRMs/DSMs and did not increase GM1 surface expression in vitro. We previously reported treatment of EL4 cells with DHA, but not EPA, increased raft size (18). Thus, we conducted comparative biochemical and imaging studies to determine if the in vivo and in vitro modes of raft disruption were similar in addition to discriminating differences in bioactivity of EPA vs. DHA.
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Similar to ex vivo measurements, relative PC and SM levels were higher in DRMs than DSMs and were not affected by EPA or DHA (Fig. 4A) . In PE, EPA treatment increased 20:5 and 22:5 in DRMs. DHA treatment had no significant effect on 22:6 in DRMs of PE (Fig. 4B) . In PE DSMs, EPA and DHA treatment lowered 20:4 and DHA increased 22:6 (Fig. 4B) . In PCs, EPA and DHA treatment did not significantly increase 20:5 or 22:6 in DRMs (Fig. 4C) Cholesterol levels in the DRM and DSM fractions were not significantly changed with EPA or DHA treatment (Suppl. Table 2 ). There was a tendency for EPA treatment to lower DRM cholesterol relative to BSA when analyzed as a t-test (p<0.05). The ratio of cholesterol in DRM to DSM also had a tendency to be lowered with EPA and DHA treatment (p=0.08) (Suppl. Table 2 ). Finally, we measured GM1 surface levels using microscopy before and after cross-linking and found no effect of EPA or DHA treatment (Suppl. Fig. 4 ). These results showed in vitro treatment with EPA/DHA, consistent with most other in vitro studies, changed DRM composition (19, 32); however, we did not measure an increase in GM1 levels in vitro with EPA or DHA treatment as observed ex vivo.
DHA, but not EPA, increased membrane order with cross-linking relative to the absence of cross-linking in vitro. We next determined if EPA and DHA treatment increased membrane order, as measured ex vivo. In the absence of cross-linking, EPA and DHA respectively, compared to BSA, decreased GP by 32% and 75% (Fig. 5A) .
Upon cross-linking, EPA showed no difference in molecular order relative to BSA;
however, DHA treatment lowered GP by 27% (Fig. 5B) . Analysis of the differences in GP values between cross-linking relative to no cross-linking showed DHA, but not EPA, had a greater ordering effect by 60% compared to BSA (Fig. 5C ). These results supported the emerging ex vivo model that an n-3 PUFA exerts an ordering effect upon induction of raft formation (6) . surface levels were increased by 22% with FO while MHC class II and CD80 surface expression were not affected by FO (Fig. 6A) . Secretion of IL-6, TNFα, and IFNγ were 18 increased compared with FO relative to the CON by 43%, 87%, and 182% (Fig. 6B) . IL-10 secretion was unaffected with the FO diet (Fig. 6B) .
We then determined if the immune enhancing effect of the FO diet on B cells was specific to the innate response or also applicable to an adaptive immune response.
Thus, we tested the ability of B cells isolated from FO fed mice to stimulate transgenic naïve CD4 + T cells that were not from FO fed mice (Fig. 7) . The concentration of (Fig. 7A) . Analysis of secreted cytokines revealed IFNγ levels were not significantly decreased with FO but IL-2 secretion was decreased by 42% with the FO diet, relative to CON (Fig. 7B) . These results supported the notion that raft disruption with FO was accompanied by changes in B cell function.
DISCUSSION
In this study, we focused on B cells, a cell type underrepresented in experiments with n-3 PUFAs, especially at the animal level. The results demonstrated several significant advancements. First, the data showed that a relevant dose of FO increased the size of B cell rafts. Next, data integrated from animals, cell culture, and model membranes, challenged some models on how n-3 PUFAs disrupted raft molecular organization. Third, the data highlighted differences between EPA and DHA on membrane organization. Finally, we discovered a physiologically relevant dose of FO enhanced an innate immune response but suppressed an adaptive response.
Therefore, the data also challenged the paradigm that modification of rafts with FO exerts global immunosuppressive effects, but overall supported the notion that manipulation of immune cell rafts with FO was accompanied by changes in function.
Biochemical measurements revealed some differences between ex vivo and in vitro measurements. The biochemical data from B cells (Fig. 1) were generally in agreement with ex vivo studies with a few exceptions (12, 33) . Fan et al., demonstrated biochemically that n-3 PUFAs infiltrated DRMs and DSMs differentially depending on the type of headgroup (34) . Their data showed the majority of n-3 PUFAs displayed a preference for inner leaflet lipids such as PEs. We also found greater incorporation of n-3 PUFAs into PEs over PCs. However, in the Fan et al. study, they reported that n-3
PUFAs incorporated in PE DRMs whereas we observed the majority of n-3 PUFAs in DSMs of PEs (Fig. 1) . We also found DHA in PC DRMs whereas they found no n-3
PUFAs in PC DRMs. Finally, we observed an increase in surface levels of GM1, a sphingolipid, whereas the same group reported a decrease in SM in a subsequent study (33) . The differences between the studies could be cell specific or due to differences in diet compositions.
The B cell biochemical data showing DHA incorporated more into DRM PC than PE were consistent with model membrane experiments on lipid mixtures containing raft molecules (SM and cholesterol). They showed a DHA-containing PC underwent a greater increase in molecular order upon adding cholesterol compared to a DHAcontaining PE (Table 2) . These results were in agreement with previous studies to show cholesterol was more soluble in n-3 PUFAs containing PCs than PEs (27). It is also important to note that the DHA-containing PC underwent a substantial increase in molecular order when exposed to cholesterol in the mixture with SM, which was consistent with the increase in membrane molecular order observed ex vivo when comparing cross-linked rafts to the absence of cross-linking with FO (Fig. 3) . Although n-3 PUFA acyl chains are highly disordered, very recent data from Mihailescu et al.,
revealed cholesterol could raise the order of a PC-containing DHA (35) . Thus, the model membrane data suggest that since a PC containing DHA underwent an ordering effect upon interaction with cholesterol, this would allow the PC-containing DHA to favorably incorporate into rafts.
Our ex vivo and in vitro data did not concur with some in vitro measurements from other labs on cholesterol lateral distribution in DRMs and DSMs. Grimm et al.,
reported that treatment of SH-SY5Y cells with 100 µM DHA increased the normalized DSM/DRM ratio (9). We did not observe differences in cholesterol levels between DRM and DSMs in B cells or EL4 cells; however, the DRM/DSM ratio tended to be lowered in EL4 cells (Suppl. Table 2 ). More work is clearly needed in this area since a very recent reported that treatment of hepatocytes with EPA increased raft cholesterol levels, opposite of the findings reported by Grimm and co-workers (10).
There were a few differences between the B cell biochemical data compared to the in vitro studies using EL4 cells. The first major difference was GM1 levels were increased ex vivo with FO but not in vitro. The second major difference was that EPA/DHA did not dramatically infiltrate DRMs ex vivo compared to in vitro. Our in vitro data were in agreement with cell culture studies from other labs (19, 32). For example, Stulnig and co-workers showed that treatment of Jurkat T cells with EPA resulted in significant incorporation into DRMs and DSMs of SM, PC, and PEs (19). We also observed some uptake of n-3 PUFAs into the SM fraction in both cell types, similar to Stulnig's lab; however, it is possible that the SM fraction could contain some small contaminants from other phospholipids such as phosphatidylinositols and phosphatidylserines.
Overall, we hypothesize that the differences between our ex vivo and in vitro studies were due to differences in cell types (primary vs. immortal) and methods of lipid delivery (diet vs. exogenous addition of EPA or DHA). Furthermore, the levels of fatty acids (data not shown) and cholesterol (Suppl. 
Imaging demonstrated FO increased membrane order upon cross-linking.
Detergent extraction is a predictive tool but can induce artifacts (28, 29). An alternative method would have been to conduct studies with detergent-free methods to isolate rafts (36); however, this was beyond the scope of the study. We discovered, consistent with others, that detergent-free methods required very large number of cells (>100x10 6 ) to isolate rafts (37) . Therefore, we relied heavily on imaging to determine how FO disrupted raft organization upon CTxB cross-linking.
The ex vivo imaging data (Fig. 2,3 ) were highly consistent with ex vivo data to show fat-1 mice, which express high endogenous levels of n-3 PUFAs, displayed increased molecular order within the CD4 + T cell immunological synapse upon activation with a cognate hybridoma cell, relative to non-synapse regions (6) . Similarly, we observed that cross-linking GM1 molecules of B cells from FO fed mice had a greater increase in molecular order relative to no cross-linking (Fig. 3) . Supporting in vitro studies showed DHA, but not EPA, increased membrane molecular order upon cross-linking relative to no cross-linking (Fig. 5) . These results were novel since very little is known about the differences in bioactivity between EPA and DHA on membrane organization.
The ex vivo and in vitro imaging data were in agreement with our previous studies. We showed previously that treatment of EL4 cells with DHA, but not EPA, diminished CTxB induced clustering of EL4 cells (18). We also discovered administration of a very high dose of a fish/flaxseed oil enriched diet to mice disrupted B cell raft organization with no impact on non-raft organization (15) . In this study, the data were the first evidence for changes in B cell raft organization with a physiologically relevant dose of FO.
Emerging model by which FO increases raft size. We propose the following working model to explain the ex vivo and in vitro data. In the absence of cross-linking, n-3 PUFA incorporation into the membrane, either through the diet or in culture, decreased membrane order due to the highly disordered nature of the n-3 PUFA acyl chains (31).
In vivo, FO also enhanced GM1 surface levels, which could be due to targeting of GM1 biosynthesis and/or trafficking to the plasma membrane. Although the GM1 molecules were poised to form rafts in the absence of cross-linking, they were not in a state where large scale phase separation could be observed (38, 39) .
Upon cross-linking CTxB, the membrane became more ordered as lipid molecules were forced together and micron scale domains became visible with FO. We speculate FO administration resulted in the trapping of n-3 PUFAs into the large scale raft domains. Cholesterol was not displaced out of the rafts in either model system.
Instead, the mixing of cholesterol with n-3 PUFAs had an ordering effect on the membrane, as demonstrated with model membrane studies. In vitro studies demonstrated the effects on membrane order were driven by DHA rather than EPA.
Overall, our data supported the model that FO can exert an ordering effect as opposed to other models discussed above (6) .
Disruption of rafts with FO was accompanied by differential effects on innate and
adaptive B cell functions. The previous work on how FO disrupts rafts and the subsequent impact on immune cell function has centered on CD4 + T cells, macrophages, and splenocytes (6, 11, 12) . Generally, manipulation of lipid microdomain organization (which may have utility as a biomarker of n-3 PUFA manipulation) with n-3
PUFAs was reported to be accompanied by immunosuppression. Here we discovered LPS stimulation of B cells increased cytokine secretion (Fig. 6) . The data were similar to a few studies that showed activation of splenic macrophages with LPS resulted in increased cytokine secretion with FO (40) (41) (42) . The data were also in agreement with our previous report to show that very long-term administration of a high fat fish/flaxseed oil enriched diet enhanced activation of B cells (16) . We had previously suggested that the increase in B cell activation was due to body weight gain, which we now know is not the driving factor.
The functional data ( 
